(Alliance News) - GSK PLC on Friday said it received GBP885.6 million in gross proceeds from its sale of shares in consumer healthcare spin-off Haleon PLC. Read More
(Alliance News) - The FTSE 100 was outperforming its European peers at midday on Tuesday, amid news that UK consumer price inflation is decelerating and the government is scrapping some rules to boost housebuilding. Read More
(Alliance News) - Stocks in London closed in the red on Friday, as markets worried that better-than-expected economic growth in the UK during the second-quarter of the year may prompt the Bank of England to keep interest rates higher for longer. Read More
(Alliance News) - Sky News reported on Sunday that Inflexion Private Equity Partners is among suitors for Haleon PLC's Nicotinell anti-smoking aid. Read More
(Alliance News) - Stocks in London are expected to open lower on Monday, with markets seeing little reason to head higher in a quiet start to the week. Read More
(Alliance News) - Haleon PLC on Wednesday upped its annual organic revenue growth guidance following a solid revenue performance in the first half of 2023. Read More
(Alliance News) - Futura Medical PLC on Monday said it agreed a licensing deal with Haleon PLC for the rights to exclusively commercialise Futura's erectile dysfunction treatment Med3000 in the US. Read More
(Alliance News) - UK equities are "under-owned" and cheap, Barclays said on Friday, as its analysts set out some of the investment bank's conviction stock ideas for the coming quarter. Read More
(Alliance News) - Haleon PLC is exploring a potential divestment of some smoking cessation products, including the Nicotinell brand of nicotine gum, patches and lozenges, according to a Bloomberg report on Tuesday. Read More
(Alliance News) - Stocks in London closed lower on Friday as weak economic data and the prospect of global interests staying higher for longer put investors in a firmly risk-off mood. Read More
(Alliance News) - Stock prices in London were lower heading into Friday afternoon, as a poor week for equities continued, with investors fretting over the prospect of central banks keeping interest rates higher for longer. Read More
(Alliance News) - GSK PLC on Friday said a Zantac trial set to begin next month in California has been dismissed after it reached a confidential settlement. Read More
